Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Madison H. McMinn et al.|Neuro-Oncology|2021Cited by 81
Light-regulated allosteric switch enables temporal and subcellular control of enzyme activityMark Shaaya, Andrei V. Karginov, Jordan Fauser et al.|eLife|2020Cited by 55
Quantitative Consequences of Protein Carriers in Immunopeptidomics and Tyrosine Phosphorylation MS2 AnalysesLauren Stopfer, Forest M. White, Jason E. Conage‐Pough|Molecular & Cellular Proteomics|2021Cited by 35
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Nataly Kravchenko‐Balasha, Jason E. Conage‐Pough et al.|Molecular Cancer|2024Cited by 12
Differential substrate specificity of ERK, JNK, and p38 MAP kinases toward connexin 43Lauren P Latchford, Anastasia F. Thévenin, Liz S Perez et al.|Journal of Biological Chemistry|2025Cited by 10